Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prostaglandins are a group of physiologically active lipid compounds classified as eicosanoids, which have diverse hormone-like effects in animals and humans. They are synthesized from arachidonic acid and act locally via G-protein coupled receptors to regulate inflammation, vascular tone, reproduction, and gastrointestinal function. Drugs targeting prostaglandin synthesis or receptors are used for a variety of therapeutic purposes, including pain relief, ulcer prevention, and glaucoma management.
Binding to G-protein coupled receptors (GPCRs) such as EP1-EP4, IP, TP, DP, and FP receptors, leading to various downstream signaling cascades depending on the receptor subtype and tissue distribution. NSAIDs inhibit prostaglandin synthesis by blocking cyclooxygenase (COX) enzymes.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostaglandins (PGs).